Blueprint Medicines Statistics
Total Valuation
AKR has a market cap or net worth of $2.52 billion. The enterprise value is $4.31 billion.
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
AKR has 136.22 million shares outstanding. The number of shares has increased by 21.01% in one year.
| Current Share Class | 131.01M |
| Shares Outstanding | 136.22M |
| Shares Change (YoY) | +21.01% |
| Shares Change (QoQ) | +7.96% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 107.90% |
| Float | 130.30M |
Valuation Ratios
The trailing PE ratio is 116.90 and the forward PE ratio is 50.05. AKR's PEG ratio is 10.67.
| Price/FFO Ratio | 15.40 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 116.90 |
| Forward PE | 50.05 |
| PS Ratio | 5.66 |
| Forward PS | 6.58 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 10.67 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 224.21 |
| EV / Sales | 10.99 |
| EV / EBITDA | 18.83 |
| EV / EBIT | 52.09 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.04 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 7.81 |
| Debt / FCF | n/a |
| Interest Coverage | 0.90 |
Financial Efficiency
Return on equity (ROE) is -0.77% and return on invested capital (ROIC) is 1.20%.
| Return on Equity (ROE) | -0.77% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | 1.20% |
| Return on Capital Employed (ROCE) | 1.81% |
| Revenue Per Employee | $3.04M |
| Profits Per Employee | $148,992 |
| Employee Count | 129 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.92 |
Taxes
In the past 12 months, AKR has paid $353,000 in taxes.
| Income Tax | 353,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.51% in the last 52 weeks. The beta is 1.38, so AKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -14.51% |
| 50-Day Moving Average | 18.92 |
| 200-Day Moving Average | 21.74 |
| Relative Strength Index (RSI) | 45.71 |
| Average Volume (20 Days) | 1,589,603 |
Short Selling Information
The latest short interest is 7.44 million, so 5.46% of the outstanding shares have been sold short.
| Short Interest | 7.44M |
| Short Previous Month | 5.61M |
| Short % of Shares Out | 5.46% |
| Short % of Float | 5.71% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, AKR had revenue of $392.14 million and earned $19.22 million in profits. Earnings per share was $0.16.
| Revenue | 392.14M |
| Gross Profit | 274.88M |
| Operating Income | 82.74M |
| Pretax Income | 2.15M |
| Net Income | 19.22M |
| EBITDA | 228.91M |
| EBIT | 82.74M |
| Earnings Per Share (EPS) | $0.16 |
Full Income StatementBalance Sheet
The company has $42.78 million in cash and $1.83 billion in debt, giving a net cash position of -$1.79 billion or -$13.14 per share.
| Cash & Cash Equivalents | 42.78M |
| Total Debt | 1.83B |
| Net Cash | -1.79B |
| Net Cash Per Share | -$13.14 |
| Equity (Book Value) | 2.73B |
| Book Value Per Share | 17.32 |
| Working Capital | 13.43M |
Full Balance SheetMargins
Gross margin is 70.10%, with operating and profit margins of 21.10% and 5.23%.
| Gross Margin | 70.10% |
| Operating Margin | 21.10% |
| Pretax Margin | -4.80% |
| Profit Margin | 5.23% |
| EBITDA Margin | 58.37% |
| EBIT Margin | 21.10% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 4.27%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 4.27% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 492.86% |
| Buyback Yield | -21.01% |
| Shareholder Yield | -16.73% |
| Earnings Yield | 0.76% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for AKR is $25.00, which is 35.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 35.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.60% |
| EPS Growth Forecast (5Y) | 21.22% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
